
### [MONDO:0015897](http://purl.obolibrary.org/obo/MONDO_0015897)
**Label:** rare hyperparathyroidism

**Subclasses:** [MONDO:0010837](http://purl.obolibrary.org/obo/MONDO_0010837) (primary hyperparathyroidism (disease)), [MONDO:0007768](http://purl.obolibrary.org/obo/MONDO_0007768) (hyperparathyroidism-jaw tumor syndrome), [MONDO:0007767](http://purl.obolibrary.org/obo/MONDO_0007767) (hyperparathyroidism 1), [MONDO:0015027](http://purl.obolibrary.org/obo/MONDO_0015027) (familial isolated hyperparathyroidism), [MONDO:0016166](http://purl.obolibrary.org/obo/MONDO_0016166) (genetic hyperparathyroidism), [MONDO:0009397](http://purl.obolibrary.org/obo/MONDO_0009397) (neonatal severe primary hyperparathyroidism), [MONDO:0016365](http://purl.obolibrary.org/obo/MONDO_0016365) (familial primary hyperparathyroidism), [MONDO:0007540](http://purl.obolibrary.org/obo/MONDO_0007540) (multiple endocrine neoplasia type 1), [MONDO:0012004](http://purl.obolibrary.org/obo/MONDO_0012004) (parathyroid gland carcinoma), [MONDO:0012406](http://purl.obolibrary.org/obo/MONDO_0012406) (HRPT3), [MONDO:0020524](http://purl.obolibrary.org/obo/MONDO_0020524) (primary parathyroid hyperplasia), 

**Mapped go classes:** [GO:2001173](http://purl.obolibrary.org/obo/GO_2001173) (regulation of histone H2B conserved C-terminal lysine ubiquitination), [GO:0007254](http://purl.obolibrary.org/obo/GO_0007254) (JNK cascade), [GO:0048754](http://purl.obolibrary.org/obo/GO_0048754) (branching morphogenesis of an epithelial tube), [GO:0032968](http://purl.obolibrary.org/obo/GO_0032968) (positive regulation of transcription elongation from RNA polymerase II promoter), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:2001209](http://purl.obolibrary.org/obo/GO_2001209) (positive regulation of transcription elongation from RNA polymerase I promoter), [GO:0051924](http://purl.obolibrary.org/obo/GO_0051924) (regulation of calcium ion transport), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0010390](http://purl.obolibrary.org/obo/GO_0010390) (histone monoubiquitination), [GO:0044325](http://purl.obolibrary.org/obo/GO_0044325) (ion channel binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005513](http://purl.obolibrary.org/obo/GO_0005513) (detection of calcium ion), [GO:0009957](http://purl.obolibrary.org/obo/GO_0009957) (epidermal cell fate specification), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0001711](http://purl.obolibrary.org/obo/GO_0001711) (endodermal cell fate commitment), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0001558](http://purl.obolibrary.org/obo/GO_0001558) (regulation of cell growth), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0018024](http://purl.obolibrary.org/obo/GO_0018024) (histone-lysine N-methyltransferase activity), [GO:0033523](http://purl.obolibrary.org/obo/GO_0033523) (histone H2B ubiquitination), [GO:0007193](http://purl.obolibrary.org/obo/GO_0007193) (adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway), [GO:0070509](http://purl.obolibrary.org/obo/GO_0070509) (calcium ion import), [GO:0055074](http://purl.obolibrary.org/obo/GO_0055074) (calcium ion homeostasis), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0055078](http://purl.obolibrary.org/obo/GO_0055078) (sodium ion homeostasis), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0005178](http://purl.obolibrary.org/obo/GO_0005178) (integrin binding), [GO:0042311](http://purl.obolibrary.org/obo/GO_0042311) (vasodilation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0071310](http://purl.obolibrary.org/obo/GO_0071310) (cellular response to organic substance), [GO:1990269](http://purl.obolibrary.org/obo/GO_1990269) (RNA polymerase II C-terminal domain phosphoserine binding), [GO:0060706](http://purl.obolibrary.org/obo/GO_0060706) (cell differentiation involved in embryonic placenta development), [GO:0048147](http://purl.obolibrary.org/obo/GO_0048147) (negative regulation of fibroblast proliferation), [GO:0006816](http://purl.obolibrary.org/obo/GO_0006816) (calcium ion transport), [GO:0016593](http://purl.obolibrary.org/obo/GO_0016593) (Cdc73/Paf1 complex), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0032024](http://purl.obolibrary.org/obo/GO_0032024) (positive regulation of insulin secretion), [GO:0016597](http://purl.obolibrary.org/obo/GO_0016597) (amino acid binding), [GO:0030643](http://purl.obolibrary.org/obo/GO_0030643) (cellular phosphate ion homeostasis), [GO:0032781](http://purl.obolibrary.org/obo/GO_0032781) (positive regulation of ATPase activity), [GO:0021529](http://purl.obolibrary.org/obo/GO_0021529) (spinal cord oligodendrocyte cell differentiation), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0060017](http://purl.obolibrary.org/obo/GO_0060017) (parathyroid gland development), [GO:0090280](http://purl.obolibrary.org/obo/GO_0090280) (positive regulation of calcium ion import), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0031442](http://purl.obolibrary.org/obo/GO_0031442) (positive regulation of mRNA 3'-end processing), [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding), [GO:0006362](http://purl.obolibrary.org/obo/GO_0006362) (transcription elongation from RNA polymerase I promoter), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0006368](http://purl.obolibrary.org/obo/GO_0006368) (transcription elongation from RNA polymerase II promoter), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0042063](http://purl.obolibrary.org/obo/GO_0042063) (gliogenesis), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0016570](http://purl.obolibrary.org/obo/GO_0016570) (histone modification), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0019827](http://purl.obolibrary.org/obo/GO_0019827) (stem cell population maintenance), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0050927](http://purl.obolibrary.org/obo/GO_0050927) (positive regulation of positive chemotaxis), [GO:0090262](http://purl.obolibrary.org/obo/GO_0090262) (regulation of transcription-coupled nucleotide-excision repair), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0043679](http://purl.obolibrary.org/obo/GO_0043679) (axon terminus), [GO:0006378](http://purl.obolibrary.org/obo/GO_0006378) (mRNA polyadenylation), [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0001089](http://purl.obolibrary.org/obo/GO_0001089) (transcription factor activity, TFIIF-class transcription factor binding), [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0030177](http://purl.obolibrary.org/obo/GO_0030177) (positive regulation of Wnt signaling pathway), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:2001255](http://purl.obolibrary.org/obo/GO_2001255) (positive regulation of histone H3-K36 trimethylation), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0045907](http://purl.obolibrary.org/obo/GO_0045907) (positive regulation of vasoconstriction), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0000993](http://purl.obolibrary.org/obo/GO_0000993) (RNA polymerase II core binding), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:1902808](http://purl.obolibrary.org/obo/GO_1902808) (positive regulation of cell cycle G1/S phase transition), [GO:0034402](http://purl.obolibrary.org/obo/GO_0034402) (recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex), [GO:0045638](http://purl.obolibrary.org/obo/GO_0045638) (negative regulation of myeloid cell differentiation), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:2001165](http://purl.obolibrary.org/obo/GO_2001165) (positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0034243](http://purl.obolibrary.org/obo/GO_0034243) (regulation of transcription elongation from RNA polymerase II promoter), [GO:0019808](http://purl.obolibrary.org/obo/GO_0019808) (polyamine binding), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007200](http://purl.obolibrary.org/obo/GO_0007200) (phospholipase C-activating G-protein coupled receptor signaling pathway), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0006874](http://purl.obolibrary.org/obo/GO_0006874) (cellular calcium ion homeostasis), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0045910](http://purl.obolibrary.org/obo/GO_0045910) (negative regulation of DNA recombination), [GO:0031648](http://purl.obolibrary.org/obo/GO_0031648) (protein destabilization), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0035327](http://purl.obolibrary.org/obo/GO_0035327) (transcriptionally active chromatin), [GO:0031124](http://purl.obolibrary.org/obo/GO_0031124) (mRNA 3'-end processing), 

**Class expressions from DL-Learner:**

- Thing 53.38%
- [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide) 51.79%
- [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body) 51.79%
- [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body) 51.79%
- [GO:0035327](http://purl.obolibrary.org/obo/GO_0035327) (transcriptionally active chromatin) 51.79%
- [GO:0016593](http://purl.obolibrary.org/obo/GO_0016593) (Cdc73/Paf1 complex) 51.79%
- [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane) 51.79%
- [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane) 51.79%
- [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface) 51.79%
- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 51.79%
- [GO:0005513](http://purl.obolibrary.org/obo/GO_0005513) (detection of calcium ion) 51.79%
- [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region) 51.79%
- [GO:0000781](http://purl.obolibrary.org/obo/GO_0000781) (chromosome, telomeric region) 51.79%
- [GO:0051592](http://purl.obolibrary.org/obo/GO_0051592) (response to calcium ion) and [GO:0051606](http://purl.obolibrary.org/obo/GO_0051606) (detection of stimulus) 51.79%
- [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide) and [GO:1901701](http://purl.obolibrary.org/obo/GO_1901701) (cellular response to oxygen-containing compound) 51.79%


